Your browser doesn't support javascript.
loading
ER Stress Signaling Promotes the Survival of Cancer "Persister Cells" Tolerant to EGFR Tyrosine Kinase Inhibitors.
Terai, Hideki; Kitajima, Shunsuke; Potter, Danielle S; Matsui, Yusuke; Quiceno, Laura Gutierrez; Chen, Ting; Kim, Tae-Jung; Rusan, Maria; Thai, Tran C; Piccioni, Federica; Donovan, Katherine A; Kwiatkowski, Nicholas; Hinohara, Kunihiko; Wei, Guo; Gray, Nathanael S; Fischer, Eric S; Wong, Kwok-Kin; Shimamura, Teppei; Letai, Anthony; Hammerman, Peter S; Barbie, David A.
Afiliação
  • Terai H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Kitajima S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Potter DS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Matsui Y; Department of Systems Biology Nagoya University, Graduate School of Medicine, Nagoya, Japan.
  • Quiceno LG; Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York.
  • Chen T; Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York.
  • Kim TJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Rusan M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Thai TC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Piccioni F; Genetic Perturbation Platform, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Donovan KA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Kwiatkowski N; Department of Biological Chemistry and Molecular Pharmacology Harvard Medical School, Boston, Massachusetts.
  • Hinohara K; Department of Biological Chemistry and Molecular Pharmacology Harvard Medical School, Boston, Massachusetts.
  • Wei G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Gray NS; Cancer Program, Broad Institute or MIT and Harvard, Cambridge, Massachusetts.
  • Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wong KK; Department of Biological Chemistry and Molecular Pharmacology Harvard Medical School, Boston, Massachusetts.
  • Shimamura T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Letai A; Department of Biological Chemistry and Molecular Pharmacology Harvard Medical School, Boston, Massachusetts.
  • Hammerman PS; Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York.
  • Barbie DA; Department of Systems Biology Nagoya University, Graduate School of Medicine, Nagoya, Japan.
Cancer Res ; 78(4): 1044-1057, 2018 02 15.
Article em En | MEDLINE | ID: mdl-29259014
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sobrevivência Celular / Análise de Componente Principal / Inibidores de Proteínas Quinases / Neoplasias Pulmonares Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sobrevivência Celular / Análise de Componente Principal / Inibidores de Proteínas Quinases / Neoplasias Pulmonares Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article